Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics.
about
Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection modelA randomised controlled trial of the effect of music therapy and verbal relaxation on chemotherapy-induced anxiety.Comparative in vitro study of the antimicrobial activities of different commercial antibiotic products for intravenous administration.In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin.Comparative in vitro study of the antimicrobial activities of different commercial antibiotic products of vancomycin.Investigating the dissolution profiles of amoxicillin, metronidazole, and zidovudine formulations used in Trinidad and Tobago, West Indies.Impact on resistance of the use of therapeutically equivalent generics: the case of ciprofloxacinStudy of the Efficacy of Real Time-PCR Method for Amikacin Determination Using Microbial Assay.Therapeutic equivalence requires pharmaceutical, pharmacokinetic, and pharmacodynamic identities: true bioequivalence of a generic product of intravenous metronidazole.Pharmacodynamics of nine generic products of amikacin compared with the innovator in the neutropenic mouse thigh infection model.Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence: the case of meropenem.Development and characterization of vancomycin-loaded levan-based microparticular system for drug delivery.A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide®) to the innovator brand in critically ill patients.Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator.In Vivo Effects of Cefazolin, Daptomycin, and Nafcillin in Experimental Endocarditis with a Methicillin-Susceptible Staphylococcus aureus Strain Showing an Inoculum Effect against Cefazolin.Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations.Selection of appropriate analytical tools to determine the potency and bioactivity of antibiotics and antibiotic resistance.Opto-electrokinetic manipulation for high-performance on-chip bioassays.
P2860
Q28474000-5581975F-38AA-410E-9F03-6C4672A4D755Q30400533-8C573940-C517-4581-8272-43326505D6DCQ33527548-E5DC1B74-47E0-4647-A2D6-C2F6BE4F6139Q33595346-1F03DA79-B678-494B-BA90-3BFE39090321Q33967355-D6E309D9-699C-4D09-974A-E223EB447484Q34265189-6290FE98-7FFA-451D-8257-CFDA03D3CC8FQ34922857-6520AD3C-8EA7-4A50-86E4-1BB7847EC633Q35895245-B0A86AA2-1B7E-45E1-89BD-8D2F21294A16Q35941429-A1E44E7C-AA1A-406B-91C1-372DD8497418Q36131630-8AF4FD78-546B-48A4-8DBA-FD6B3843506DQ37544589-1B8120C7-FFAD-4FA9-9CC5-664F262CAD24Q40274343-AC257653-C512-47E0-8117-CB5DCD9F9BE4Q41788745-8EC62351-5510-42F7-9406-456A62A121BCQ41890029-C2C89F1D-193D-44DC-9AAE-C8F9F72166B9Q42110143-020DCB2D-8182-43A9-BE5E-0561C5523A81Q49272482-7FF7AD6F-E587-4F6E-BAF5-4977615C1A97Q50196433-41FB6F8C-B413-46D9-A812-52F8F743ED32Q51536052-6F5929F0-A3BE-4FA0-BECF-EB4AF6A69E30
P2860
Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Application of microbiological ...... neric intravenous antibiotics.
@ast
Application of microbiological ...... neric intravenous antibiotics.
@en
type
label
Application of microbiological ...... neric intravenous antibiotics.
@ast
Application of microbiological ...... neric intravenous antibiotics.
@en
prefLabel
Application of microbiological ...... neric intravenous antibiotics.
@ast
Application of microbiological ...... neric intravenous antibiotics.
@en
P2860
P356
P1476
Application of microbiological ...... neric intravenous antibiotics.
@en
P2093
Maria Agudelo
Omar Vesga
P2860
P2888
P356
10.1186/1472-6904-9-1
P577
2009-01-16T00:00:00Z
P5875
P6179
1019041173